Cancer Genomics
- Cancer PHGKB -
What's New
Last Posted: Aug 02, 2018
- A Review of Molecular Predictors of Response to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer.
Degener Stephan et al. Mini reviews in medicinal chemistry 2018 18(13) 1133-1142 - A systematic review on the frequency of BRCA promoter methylation in breast and ovarian carcinomas of BRCA germline mutation carriers: Mutually exclusive, or not?
Vos Shoko et al. Critical reviews in oncology/hematology 2018 Jul 12729-41 - Application of 21-gene recurrence score results and ASTRO suitability criteria in breast cancer patients treated with intraoperative radiation therapy (IORT).
Schwartzberg Barbara S et al. American journal of surgery 2018 Jul - Blood based biomarkers beyond genomics for lung cancer screening.
Hanash Samir M et al. Translational lung cancer research 2018 Jun 7(3) 327-335 - BRCA1 founder mutations and beyond in the Polish population: A single-institution BRCA1/2 next-generation sequencing study.
Kowalik Artur et al. PloS one 2018 13(7) e0201086 - Coping Mechanisms, Psychological Distress, and Quality of Life Prior to Cancer Genetic Counseling.
Di Mattei Valentina E et al. Frontiers in psychology 2018 91218 - Current Tissue Molecular Markers in Colorectal Cancer: A Literature Review.
Peluso Gaia et al. BioMed research international 2017 20172605628 - DNA breakpoint assay reveals a majority of gross duplications occur in tandem reducing VUS classifications in breast cancer predisposition genes.
Richardson Marcy E et al. Genetics in medicine : official journal of the American College of Medical Genetics 2018 Jul - Identification of Germline Variants in Tumor Genomic Sequencing Analysis.
Montgomery Nathan D et al. The Journal of molecular diagnostics : JMD 2018 Jan 20(1) 123-125 - Liquid Biopsy, Key for Precision Medicine Sequencing Circulating Tumor DNA Can Provide a More Complete Molecular Picture
A Picher, GEN News, July 23, 2018
No hay comentarios:
Publicar un comentario